Definitive Contract 75F40122C00078
Award Date
7/10/22
Potential Completion Date
7/31/27
Potential Value
$1.9M
Federal Agency
Food and Drug Administration
Awardee
Ohio Department Of Health
Ultimate Awardee
Not listed
NAICS Category
923120 - Administration of Public Health Programs
PSC Category
H265 - Equipment And Materials Testing- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Columbus, OH 43215, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...
This is a federal contract awarded by the Food and Drug Administration (FDA) to the Commonwealth of Virginia State Board of Health Office of Epidemiology Division, doing business as Office of Epidemiology-Central Office. The contract has a ceiling value of $371,732.40 and is a definitive, firm fixed-price contract. The contract period of performance is from September 30, 2015 to September 29, 2016, with one option period. The contract is not set aside. The contract provides for services...
This is a $229,473.61 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Executive Office of the Governor of Delaware, Division of Public Health, to conduct inspections of certified non-federal mammography facilities in Delaware. The contract is for five years, with a period of performance ending on August 31, 2027. The contract was awarded as a sole-source to the Division of Public Health, as it is the state entity that possesses the legal authority...
This is a $1,337,028.39 firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to the Virginia State Board of Health (VA SBOH) for the VA Mammography Quality Standards Act (MQSA) program. The contract, which runs through March 2028, is not set aside for any specific business type. The VA SBOH, a state government entity, will be responsible for ensuring proper equipment, training, and procedures at mammography facilities across Virginia through this contract. The VA SBOH...
This is a sole source, definitive contract awarded by the Food and Drug Administration (FDA) to the Pennsylvania Department of Environmental Protection (DEP) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has a ceiling value of $3,364,865.52 and a period of performance through September 19, 2026. The contract was awarded without a set-aside designation. It...
This contract was awarded by the Food and Drug Administration (FDA) to the Arizona Department of Health Services (ADHS), a state government entity, to conduct inspections of certified non-federal mammography facilities in Arizona. The contract, valued at $1,911,936.08, is a definitive, firm-fixed-price contract with a period of performance through March 29, 2028. The original solicitation was a sole-source procurement, as the inspections require legal authority under state law and experience...
This is a $1,556,614.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to the Oregon Health Authority (OHA), a state government agency. The contract is for the OREGON MQSA NEW CONTRACT, which does not have a set-aside designation. OHA will provide a range of public health services, including newborn screening, vital statistics reporting, and environmental laboratory accreditation services, to support the FDA's regulatory oversight of medical facilities and public...
This is a $370,094.84 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to the State of Utah Department of Environmental Quality (UDEQ) to conduct inspections of certified non-federal mammography facilities. The contract supports the Mammography Quality Standards Act (MQSA) program, which requires regular inspections to ensure compliance with quality standards. As a state government agency, UDEQ has the legal authority and experienced personnel necessary to...
The U.S. Food and Drug Administration (FDA) awarded a $262,548.81 firm fixed-price contract to the South Dakota Department of Health (SD DOH) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This contract, awarded on June 30, 2022, has an ultimate completion date of January 1, 2028. The contract was issued as a sole-source award, as the state government organization is the...